Masaru Matsuda
CIK 1798679 · See Remarks · last filed 2026-05-06
Masaru Matsuda is a corporate insider who has filed 34 SEC Form 4 insider transactions across 2 companies since 2020. The most recent filing shows the insider sold $192.4K of ARQT on May 6, 2026. Across all open-market trades the lifetime net is −$3.1M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $3.1M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$3.11M
2
34
-$3.06M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| ARQT | See Remarks | 127,573 | $24.38 | $3.11M | -$3.06M | 28 | 2026-05-06 |
| HALOZYME THERAPEUTICS, INC. (HTI) Delisted | SVP, General Counsel | 20,049 | — | — | $0 | 6 | 2021-09-07 |
Recent Filings
34 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-05-06 | ARQT | Sell (S) | −8,256 | -$192.4K | EDGAR |
| 2026-03-03 | ARQT | Mixed | +24,942 | -$313.9K | EDGAR |
| 2026-02-04 | ARQT | Sell (S) | −40,638 | -$1.03M | EDGAR |
| 2025-12-03 | ARQT | Sell (S) | −1,657 | -$50.1K | EDGAR |
| 2025-11-21 | ARQT | Sell (S) | −2,550 | -$72.1K | EDGAR |
| 2025-11-05 | ARQT | Sell (S) | −7,208 | -$178.2K | EDGAR |
| 2025-09-08 | ARQT | Sell (S) | −36,130 | -$583.7K | EDGAR |
| 2025-08-05 | ARQT | Sell (S) | −6,330 | -$90.7K | EDGAR |
| 2025-05-29 | ARQT | Sell (S) | −1,800 | -$24.8K | EDGAR |
| 2025-05-05 | ARQT | Sell (S) | −5,030 | -$76.5K | EDGAR |